Preprint · OA via OpenAlex

Future glucose-lowering drugs for type 2 diabetes

Clifford J. Bailey, Abd A. Tahrani, Anthony Barnett

The Lancet Diabetes & Endocrinology · 2016 · ▲ 96 citations

Deregulated nutrient-sensing

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/s2213-8587(15)00462-3
Canonical: link ↗
Fetched: 2026-09-02 MST

Cite this

APA

Bailey, C.J., Tahrani, A.A., & Barnett, A. (2016). Future glucose-lowering drugs for type 2 diabetes. <em>The Lancet Diabetes & Endocrinology</em>. https://doi.org/10.1016/s2213-8587(15)00462-3

Vancouver

Bailey CJ, Tahrani AA, Barnett A. Future glucose-lowering drugs for type 2 diabetes. The Lancet Diabetes & Endocrinology. 2016. doi:10.1016/s2213-8587(15)00462-3.

BibTeX

@unpublished{clifford2016Future, title = {Future glucose-lowering drugs for type 2 diabetes}, author = {Clifford J. Bailey and Abd A. Tahrani and Anthony Barnett}, journal = {The Lancet Diabetes & Endocrinology}, year = {2016}, doi = {10.1016/s2213-8587(15)00462-3}, }